v3.26.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Jul. 31, 2026
Jul. 31, 2025
Consolidated Statements of Operations [Abstract]        
Net sales and revenue $ 168,493 $ 158,563 $ 324,992 $ 316,903
Production tax credit income 18,410 0 25,959 0
Cost of sales (includes $21,243 and $29,004 with related parties for the three months ended July 31, 2026 and 2025, respectively, and $40,083 and $53,853 with related parties for the six months ended July 31, 2026 and 2025, respectively.) 133,603 144,244 268,580 288,242
Gross profit 53,300 14,319 82,371 28,661
Selling, general and administrative expenses (15,622) (6,201) (25,350) (12,145)
Equity in income of unconsolidated affiliates 7,195 891 10,761 1,897
Interest and other income, net 3,245 3,088 6,451 7,310
Income before income taxes 48,118 12,097 74,233 25,723
Provision for income taxes (7,472) (2,769) (11,909) (5,723)
Net income 40,646 9,328 62,324 20,000
Net income attributable to noncontrolling interests (5,702) (2,217) (8,928) (4,211)
Net income attributable to REX common shareholders $ 34,944 $ 7,111 $ 53,396 $ 15,789
Weighted average shares outstanding – basic (in Shares) 33,090 33,010 33,019 33,388
Weighted average shares outstanding – diluted (in Shares) 33,090 33,010 33,019 33,388
Basic net income per share attributable to REX common shareholders (in Dollars per share) $ 1.06 $ 0.22 $ 1.62 $ 0.47
Diluted net income per share attributable to REX common shareholders (in Dollars per share) $ 1.06 $ 0.22 $ 1.62 $ 0.47